Bevacizumab Combined with S-1 and Raltitrexed for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies: A Phase II Study

Chen, Y; Zhou, YW; Cheng, K; Li, ZP; Luo, DY; Qiu, M; Li, Q; Wang, X; Shen, YL; Cao, D; Yang, Y; Bi, F; Liu, JY; Gou, HF

Gou, HF (corresponding author), Sichuan Univ, West China Hosp, Canc Ctr, West China Med Sch,Dept Abdominal Canc, 37 GuoXue Xiang, Chengdu 610041, Peoples R China.; Liu, JY (corresponding author), Sichuan Univ, West China Hosp, Canc Ctr, West China Med Sch,Dept Biotherapy, 37 GuoXue Xiang, Chengdu 610041, Peoples R China.

ONCOLOGIST, 2021; 26 (8): E1320

Abstract

Lessons Learned Bevacizumab combined with S-1 and raltitrexed demonstrated positive antitumor efficacy and acceptable toxicity. This combination might......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索